Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

Joep Perk, Guy De Backer, H. Gohlke et al. · European Heart Journal · 2012 · 8.5K citations · Full text

Medicine, Cardiology, Preventive Medicine +16

General Cardiovascular Risk Profile for Use in Primary Care

Ralph B. D’Agostino, Ramachandran S. Vasan, Michael Pencina et al. · Circulation · 2008 · 7.5K citations · Full text

Medicine, Cardiology, Risk Analysis +16

2016 European Guidelines on cardiovascular disease prevention in clinical practice

Massimo Piepoli, Arno W. Hoes, Stefan Agewall et al. · European Heart Journal · 2016 · 6.5K citations · Full text

Medicine, Cardiology, Internal Medicine +16

Mannheim Carotid Intima-Media Thickness and Plaque Consensus (2004–2006–2011)

Pierre‐Jean Touboul, Michael G. Hennerici, Stephen Meairs et al. · Cerebrovascular Diseases · 2012 · 1.8K citations · Full text

Medicine, Cardiology, Radiology +16

Mannheim Carotid Intima-Media Thickness Consensus (2004–2006)

Pierre‐Jean Touboul, Michael G. Hennerici, Stephen Meairs et al. · Cerebrovascular Diseases · 2006 · 1.5K citations · Full text

Medicine, Cardiology, Radiology +15